Prospective randomized trial of moderately strenuous aerobic exercise after an implantable cardioverter defibrillator
- PMID: 25792557
- PMCID: PMC4447571
- DOI: 10.1161/CIRCULATIONAHA.114.014444
Prospective randomized trial of moderately strenuous aerobic exercise after an implantable cardioverter defibrillator
Abstract
Background: Despite its salutary effects on health, aerobic exercise is often avoided after receipt of an implantable cardioverter defibrillator (ICD) because of fears that exercise may provoke acute arrhythmias. We prospectively evaluated the effects of a home aerobic exercise training and maintenance program (EX) on aerobic performance, ICD shocks, and hospitalizations exclusively in ICD recipients.
Methods and results: A total of 160 patients (124 men and 36 women) were randomly assigned who had an ICD for primary (43%) or secondary (57%) prevention to EX or usual care (UC). The primary outcome was peak oxygen consumption, measured with cardiopulmonary exercise testing at baseline and 8 and 24 weeks. EX consisted of 8 weeks of home walking for 1 h/d, 5 d/wk at 60% to 80% of heart rate reserve, followed by 16 weeks of maintenance home walking for 150 min/wk. Adherence to EX was determined from exercise logs, ambulatory heart rate recordings of exercise, and weekly telephone contacts. Patients assigned to UC received no exercise directives and were monitored by monthly telephone contact. Adverse events were identified by ICD interrogations, patient reports, and medical charts. ICD recipients averaged 55±12 years and mean ejection fraction of 40.6±15.7; all were taking β-blocker medications. EX significantly increased peak oxygen consumption (EX, 26.7±7.0 mL/kg per minute; UC, 23.9±6.6 mL/kg per minute; P=0.002) at 8 weeks, which persisted during maintenance exercise at 24 weeks (EX, 26.9±7.7 mL/kg per minute; UC, 23.4±6.0 mL/kg per minute; P<0.001). ICD shocks were infrequent (EX=4 versus UC=8), with no differences in hospitalizations or deaths between groups.
Conclusions: Prescribed home exercise is safe and significantly improves cardiovascular performance in ICD recipients without causing shocks or hospitalizations.
Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00522340.
Keywords: arrhythmias, cardiac; defibrillators, implantable; exercise; heart arrest; heart rate.
© 2015 American Heart Association, Inc.
Figures
Comment in
-
Letter by Ayoub Regarding Article, "Prospective Randomized Trial of Moderately Strenuous Aerobic Exercise After an Implantable Cardioverter Defibrillator".Circulation. 2015 Dec 15;132(24):e380. doi: 10.1161/CIRCULATIONAHA.115.017955. Circulation. 2015. PMID: 26667102 No abstract available.
-
Response to Letter Regarding Article, "Prospective Randomized Trial of Moderately Strenuous Aerobic Exercise After an Implantable Cardioverter Defibrillator".Circulation. 2015 Dec 15;132(24):e381. doi: 10.1161/CIRCULATIONAHA.115.018778. Circulation. 2015. PMID: 26667103 Free PMC article. No abstract available.
Similar articles
-
Aerobic Exercise Effects on Quality of Life and Psychological Distress After an Implantable Cardioverter Defibrillator.J Cardiopulm Rehabil Prev. 2020 Mar;40(2):94-101. doi: 10.1097/HCR.0000000000000444. J Cardiopulm Rehabil Prev. 2020. PMID: 31397768 Free PMC article.
-
Adherence to an Aerobic Exercise Intervention after an Implantable Cardioverter Defibrillator (ICD).Pacing Clin Electrophysiol. 2016 Feb;39(2):128-39. doi: 10.1111/pace.12782. Epub 2015 Dec 3. Pacing Clin Electrophysiol. 2016. PMID: 26548341 Clinical Trial.
-
Safety and Efficacy of an Early Home-Based Walking Program After Receipt of an Initial Implantable Cardioverter-Defibrillator.Arch Phys Med Rehabil. 2016 Aug;97(8):1228-36. doi: 10.1016/j.apmr.2016.02.007. Epub 2016 Mar 3. Arch Phys Med Rehabil. 2016. PMID: 26940383 Clinical Trial.
-
Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation.Eur J Prev Cardiol. 2012 Aug;19(4):804-12. doi: 10.1177/1741826711414624. Eur J Prev Cardiol. 2012. PMID: 22988593 Review.
-
Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease.JACC Clin Electrophysiol. 2019 Oct;5(10):1213-1223. doi: 10.1016/j.jacep.2019.07.003. Epub 2019 Aug 28. JACC Clin Electrophysiol. 2019. PMID: 31648747
Cited by
-
Social cognitive intervention following an initial implantable cardioverter defibrillator: Better treatment response for secondary versus primary prevention.Pacing Clin Electrophysiol. 2020 Sep;43(9):974-982. doi: 10.1111/pace.13929. Epub 2020 Aug 22. Pacing Clin Electrophysiol. 2020. PMID: 32364618 Free PMC article. Clinical Trial.
-
Wearable Devices for Exercise Prescription and Physical Activity Monitoring in Patients with Various Cardiovascular Conditions.CJC Open. 2025 Mar 3;7(5):695-706. doi: 10.1016/j.cjco.2025.02.017. eCollection 2025 May. CJC Open. 2025. PMID: 40433214 Free PMC article. Review.
-
Interventions to promote patient utilisation of cardiac rehabilitation.Cochrane Database Syst Rev. 2019 Feb 1;2(2):CD007131. doi: 10.1002/14651858.CD007131.pub4. Cochrane Database Syst Rev. 2019. PMID: 30706942 Free PMC article.
-
Protocol of randomized controlled trial to evaluate the effect of moderate exercise training on the functional capacity of patients with an implantable cardioverter defibrillator in a tertiary care center in South India.J Educ Health Promot. 2024 Nov 29;13:453. doi: 10.4103/jehp.jehp_1908_23. eCollection 2024. J Educ Health Promot. 2024. PMID: 39811835 Free PMC article.
-
The potential role of endogenous bacteriophages in controlling invading pathogens.Cell Mol Life Sci. 2005 Mar;62(5):511-9. doi: 10.1007/s00018-004-4403-6. Cell Mol Life Sci. 2005. PMID: 15747058 Free PMC article. Review.
References
-
- Kurtz SM, Ochoa JA, Lau E, Shkolnikov Y, Pavri BB, Frisch D, Greenspon AJ. Implantation trends and participant profiles for pacemakers and implantable cardioverter defibrillators in the United States:1993-2006. Pacing Clin Electrophysiol. 201033:705–711. - PubMed
-
- Cutitta KE, Woodrow LK, Ford J, Shea J, Fischer A, Hazelton G, Sears SF. Shocktivity: ability and avoidance of daily activity behaviors in ICD patients. J Cardiopulm Rehabil Prev. 2014:241–7. - PubMed
-
- Van Ittersom M, de Greef M, can Gelder I, Coster J, Brugemann J, van der Schans C. Fear of exercise and health related quality of life in participants with an ICD. Intern J Rehab Res. 2003;26:117–122. - PubMed